Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of Adalimumab and Etanercept in Children with Active Juvenile Idiopathic Arthritis
ItalyStudy on Ustekinumab and Drug Combination for Patients with Severe, Resistant Inflammatory Disease
FranceStudy on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids
The NetherlandsStudy Comparing Abatacept and Adalimumab for Adults with Early Rheumatoid Arthritis Not Responding to Methotrexate
CzechiaStudy on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study
PolandStudy of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
GermanyStudy on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety
SpainStudy on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis
AustriaStudy Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab
FranceStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
BelgiumStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
BelgiumStudy on the Safety and Imaging of Adalimumab-680LT for Patients with Inflammatory Bowel Disease
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
